Clinical characteristics and factors associated with functional outcome in patients with Guillain Barré syndrome

Yıl 2024, Cilt: 49 Sayı: 2, 460 - 470, 30.06.2024

İlkin İyigündoğdu , Eda Derle , Zeynep Kaya Güven Girgin , Sevgi İkbali Afşar , Oya Ümit Yemişçi , Berna Alkan , Seda Kibaroglu , Ülkü Sibel Benli

https://doi.org/10.17826/cumj.1431880

Öz

Purpose: We aimed to evaluate the clinical characteristics of Guillain Barré syndrome (GBS) patients retrospectively and identify the prognostic factors associated with worse outcome at discharge and at the end of the first month in patients with GBS.
Materials and Methods: Patients who were followed up with the diagnosis of GBS were evaluated retrospectively. Demographic characteristics of the patients, cerebrospinal fluid examinations, treatment regimens, Medical Research Council (MRC) and Hughes Motor Scale (HMS) scores were recorded and HMS ≥3 was accepted as associated with poor prognosis in patients. SPSS version 25 program was used in the statistical analysis of the data. p<0.05 was found to be statistically significant.
Results: After the exclusion criteria 82 patients were evaluated in this study. The mean age of patients was 56.88±17.14 years and 57.3% (n=47) of the patients were male. The most common neurological finding was paresis in the lower extremities (n=67, 81.7%) followed by paresis in the upper extremities (n=48, 58.5%). Presence of paresis in lower extremities, the median of the duration of hospitalization and the mean of MRC scores at admission were statistically significantly different in patients with poor prognosis at discharge and at the end of the first month.
Conclusion: Since patients may have different clinical and electrophysiological characteristics between countries, we believe that there is a need for various publications from different countries to collect information related to the clinical features and prognosis of patients, and we think our study will contribute to these data.

Anahtar Kelimeler

Guilain Barré syndrome, prognosis, Hughes Motor Scale

Guillain Barré sendromu olan hastaların klinik özellikleri ve fonksiyonel sonuçlarla ilişkili faktörler

Öz

Amaç: Bu çalışmada Guillain Barré sendromu (GBS) olan hastaların klinik özelliklerini retrospektif olarak değerlendirmeyi ve taburculuk ile birinci ayın sonunda kötü prognozla ilişkili prognostik faktörleri belirlemeyi amaçladık.
Gereç ve Yöntem: GBS tanısıyla takip edilen hastalar geriye dönük olarak değerlendirildi. Hastaların demografik özellikleri, beyin omurilik sıvısı sonuçları, muayene bulguları, tedavi rejimleri, Medical Research Council (MRC) ve Hughes Motor Skalası (HMS) değerleri kaydedildi ve HMS ≥3 hastalar kötü prognoz ile ilişkili kabul edildi. Verilerin istatistiksel analizinde SPSS (versiyon 25) programı kullanıldı. p<0.05 istatistiksel olarak anlamlı bulundu.
Bulgular: Dışlama kriterleri sonrasında 82 hasta çalışmaya dahil edildi. Hastaların ortalama yaşı 56.88±17.14 yıl olup, hastaların %57.3'ü (n=47) erkekti. En sık görülen nörolojik bulgu alt ekstremitede parezi (n=67, %81.7) iken bunu üst ekstremitede parezi (n=48, %58.5) izlemekteydi. Alt ekstremitede parezi varlığı, yatış süresi ortancası ve başvuru anındaki MRC skorlarının ortalaması kötü ve iyi prognozlu hastalarda taburculukta ve birinci ay sonunda istatistiksel olarak anlamlı derecede farklıydı.
Sonuç: Hastalar ülkeler arasında farklı klinik ve elektrofizyolojik özelliklere sahip olabileceğinden hastaların klinik özellikleri ve prognozlarına ilişkin bilgi toplamak için farklı ülkelerden çeşitli yayınlara ihtiyaç duyulduğunu ve çalışmamızın bu verilere katkı sağlayacağını düşünüyoruz.

Anahtar Kelimeler

Guillain Barré sendromu, prognoz, Hughes Motor Skalası

Kaynakça

• Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397:1214-28.
• Sheikh KA. Guillain-Barré syndrome. Continuum. 2020;26:1184-204.
• Tunç A. Early predictors of functional disability in Guillain-Barré syndrome. Acta Neurol Belg. 2019;119:555-9.
• López-Hernández JC, Colunga-Lozano LE, Garcia-Trejo S, Gomez-Figueroa E, Delgado-Garcia G, Bazán-Rodríguez L et al. Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barré syndrome, a single center experience. J Clin Neurosci. 2020;80:292-7.
• Zhang G, Li Q, Zhang R, Wei X, Wang J, Qin X. Subtypes and prognosis of Guillain-Barré syndrome in Southwest China. PloS One. 2015;10:e0133520.
• Verma R, Chaudhari TS, Raut TP, Garg RK. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS). J Neurol Sci. 2013;335:105-11.
• Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33-43.
• Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14:1103-9.
• Albers JW, Kelly Jr JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989;12:435-51.
• Hughes R, Newsom-Davis J, Perkin G, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;2:750-3.
• Zhai Q, Guo C, Xue F, Qiang J, Li C, Guo L. Guillain-Barré syndrome in Northern China: a retrospective analysis of 294 patients from 2015 to 2020. J Clin Med. 2022;11:6323.
• Matsui N, Nodera H, Kuzume D, Iwasa N, Unai Y, Sakai W et al. Guillain− Barré syndrome in a local area in Japan, 2006–2015: an epidemiological and clinical study of 108 patients. Eur J Neurol. 2018;25:718-24.
• Shangab M, Al Kaylani M. Clinical predictors for mechanical ventilation and prognosis in patients with Guillian-Barre syndrome: a 10-year experience. Neurol Sci. 2021;42:5305-9.
• Cetiner M, Seyit M, Akdag G, Demirbas H, Temel O, Kabay SC. Factors associated with prognosis in patients with Guillain-Barré syndrome. Turk J Neurol. 2019;25:140-5.
• Velásquez-Rimachi V, López-Saavedra AV, Rodriguez-López E, Elguera-Huaman H, Meza K, Alva-Díaz C et al. Clinical-epidemiological characteristics associated with discharge outcomes and seasonality among surviving patients with Guillain-Barré syndrome in a national third-level hospital, Lima, Peru. Arq Neuropsiquiatr. 2021;79:697-704.
• Alanazy MH, Bakry SS, Alqahtani A, AlAkeel NS, Alazwary N, Osman AM et al. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study. BMC Neurol. 2021;21:275.
• Akan O, Emir C, Orken C, Ucler S. Guillain Barre syndrome: a single center experience. Med Bull Sisli Etfal Hosp. 2020;54:73-7.
• Saba K, Hossieny ZS, Arnold WD, Elsheikh B, Palettas M, Kline D et al. CSF Protein level and short-term prognosis in Guillain–Barré syndrome. J Clin Neuromuscul Dis. 2019;21:118-9.
• Sahin S, Cinar N, Karsidag S. Are cerebrospinal fluid protein levels and plasma neutrophil/lymphocyte ratio associated with prognosis of Guillain Barré syndrome? Neurol Int. 2017;9:7032.
• Rajabally YA, Uncini A. Outcome and its predictors in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 2012;83:711-8.
• Bhagat SK, Sidhant S, Bhatta M, Ghimire A, Shah B. Clinical profile, functional outcome, and mortality of Guillain-Barre syndrome: a five-year tertiary care experience from Nepal. Neurol Res Int. 2019;2019:3867946.
• Di X, Wang J, Li L, Liu L. Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome. BMC Neurol. 2023;23:97.
• Ning P, Yang B, Yang X, Huang H, Shen Q, Zhao Q et al. Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome. J Neuroimmunol. 2021;353:577504.
• Gümüsyayla S, Vural G. The predictive value of neutrophil-lymphocyte ratio in disability of Gullain-Barrѐ syndrome. Bakırköy Tıp Dergisi. 2019;15:187-92.
• Alkan O, Yildirim T, Tokmak N, Tan M. Spinal MRI findings of Guillain-Barré syndrome. J Radiol Case Rep. 2009;3:25-8.
• Pizzo F, Di Nora A, Di Mari A, Costanza G, Testa E, Strazzieri M et al. Case report: incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome. Front Neurol. 2022;13:885897.